At the end of 2023, the FDA announced the creation of a digital health advisory committee, which will help the agency better understand the risks and benefits of emerging health care technology such as artificial intelligence and virtual reality.
This Advisory Committee will advise the FDA on a wide range of technologies such as artificial intelligence and machine learning, virtual reality, or wearables; and issues such as decentralized clinical trials, patient generated health data, or cybersecurity.
Recent Posts
Medicaid in Focus: What Audiologists Need to Know Now
With the recent changes to Medicaid, the Academy is preparing audiologists with the new one-pager, “Audiology in Medicaid”, an exclusive member resource designed to educate on…
American Academy of Audiology Clinical Consensus Statement: Assessment of Vestibular Function in the Pediatric Population
Authors: Violette Lavender, AuD, Kristen Janky, PhD, Katheryn Bachmann, PhD, Melissa Caine, AuD, Micheal Castiglione, AuD, Guangwei Zhou, ScD The American Academy of Audiology Clinical…
CMS Releases CY 2026 Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Proposed Rule
On July 15, the Centers for Medicare and Medicaid Services (CMS) released the calendar year (CY) 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System proposed rule,…